… release profile from the chitosan/TPP-hyaluronic acid nanoparticles gel formulation. …
chitosan/TPP-hyaluronic acid nanoparticle eye drop formulations are a promising platform for ocular …

… In the present study, the potential of chitosan (CS) nanoparticles as a new vehicle for the
improvement of the delivery of drugs to the ocular mucosa was investigated. Cyclosporin A (CyA…

… In this study, incorporation of CsA into cationic chitosan nanoparticles was planned with an
attempt to increase the ophthalmic contact time of CsA with the help of molecular attraction of …

… the in vivo behaviour of chitosan nanoparticles (CS NP) as ocular delivery systems for the
treatment … The interesting features of chitosan nanoparticles for ocular administration of drugs …

… Administration of drug-loaded chitosan-based nanoparticles improved both insulin 11 and
tetanus toxoid 12 27 transport across the nasal epithelium in mice. With those results in mind, …

… chitosan-nanoparticles (CSNPs) for ocular delivery of tedizolid phosphate (TZP) for the
treatment of MRSA-related ocular … After topical administration, the ocular availability of drugs is …

… Most of the reports on the topical ocular administration of chitosan … with chitosan nanoparticles.
Therefore, the conclusions from this study were that the stability of chitosan nanoparticles …

… the chitosan NPs to promote the antibacterial activity of GM against eye infections via ocular
administration. … In this study, we assessed the chitosan NP's ability to enhance the efficacy of …

… To assess the potential of chitosan (CS) nanoparticles for ocular drug delivery by investigating
their interaction with the ocular mucosa in vivo and also their toxicity in conjunctival cell …

… In addition, we observed that, following topical administration to rabbits, these nanoparticles
entered the corneal and conjunctival epithelial cells and, then, become assimilated by the …